The facts that they have already signed contract with few sites in Germany and NL, Revenue has already generated not like other biotech that just in a pre-commercialisation phrase, I am confident that the list will just keep growing.CE approval is also highly likely in EU, so AUS will eventually follow, Risk of success if very low, IMO
Ann: Top 20 Holders, page-3
Add IMR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
-0.005(0.88%) |
Mkt cap ! $115.6M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 57.0¢ | 56.0¢ | $79.95K | 141.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49237 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.5¢ | 16554 | 3 |
View Market Depth
| Last trade - 14.56pm 10/07/2024 (20 minute delay) ? |
| IMR (ASX) Chart |